Veterinary Vaccines Market to Grow with a CAGR of 7.36% through 2031F

Increase in the awareness of animal welfare and increase in the pet ownership is expected to drive the Global Veterinary Vaccines Market growth in the forecast period, 2027-2031F

According to TechSci Research report, “Veterinary Vaccines Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2031F”, the Global Veterinary Vaccines Market stood at USD 8.71 Billion in 2025 and expected to reach USD 13.34 Billion growing with a CAGR of 7.36% in the forecast period. 

The global veterinary vaccine market is being shaped by the rising incidence of infectious diseases across livestock and companion animals, because outbreaks directly reduce productivity, increase mortality, and trigger trade disruption. Diseases such as foot-and-mouth disease, avian influenza, bovine respiratory disease, and canine parvovirus continue to drive vaccination demand as producers look for preventive tools that protect herd health and stabilize supply chains. The One Health approach further strengthens this market because animal vaccination is now viewed as part of a wider strategy for safeguarding human health, food security, and environmental stability. Wildlife disease pressure is also adding urgency, especially where infection spills across domestic and wild populations. For Instance, the World Organisation for Animal Health reported more than 3,800 wildlife disease outbreaks across 55 countries in the first half of 2024, affecting 151 species, while highly pathogenic avian influenza and African swine fever accounted for most of the cases.

The veterinary vaccine market also faces pressure from rapidly evolving pathogens and the difficulty of protecting animals in wildlife reservoirs, where vaccination coverage is hard to achieve and disease control is less predictable. Antigenic variation in viruses such as influenza can reduce vaccine performance over time, forcing manufacturers to reformulate products and invest continuously in research, testing, and regulatory validation. This makes vaccine development slower and more expensive than the pace of some outbreaks, especially when novel or unpredictable pathogens emerge in livestock systems. The challenge is even greater for zoonotic diseases, because the same pathogen may circulate in domestic animals, wildlife, and humans, requiring coordinated control rather than a single-species solution. For Instance, research in animal vaccination has shown that RNA viruses can generate escape mutants under vaccine pressure, and that unusual mutations have been observed in foot-and-mouth disease and bovine respiratory syncytial virus, highlighting why continuous update cycles remain essential.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Veterinary Vaccines Market”

The Global Veterinary Vaccines Market is segmented into vaccine type, technology, regional distribution, and company.

Based on vaccine type, the companion animal vaccine segment is currently the fastest-growing part of the global veterinary vaccines market because pet owners are spending more on preventive care and veterinarians are pushing earlier immunization. Rising pet adoption, urban lifestyles, and better awareness of chronic and infectious disease prevention are increasing demand for vaccines across dogs, cats, and horses. The segment is also benefiting from newer product launches, easier administration formats, and stronger loyalty to trusted animal-health brands. This trend is visible in company performance, where companion animal portfolios are outpacing livestock in several major markets. The livestock segment remains essential, but companion vaccines are expanding faster because the customer base is broader, more recurring, and less dependent on commodity cycles. For Instance, Zoetis reported a 18% rise in companion animal revenue to 1.45 billion dollars in Q1 2024, while its full-year 2024 revenue reached about 9.3 billion dollars, showing the strength of pet-health demand.

Based on region, Asia-Pacific is poised to be the fastest-growing veterinary vaccines market because it combines rapid urbanization, rising meat consumption, and expanding pet ownership with a persistent need to control endemic livestock and poultry diseases. Governments in the region are increasingly viewing vaccination as a practical tool for protecting food security, reducing outbreak losses, and improving export readiness. The growth opportunity is also being reinforced by stronger veterinary infrastructure, wider immunization campaigns, and more investment in research for region-specific disease challenges. China and India remain central growth engines because of their large animal populations and increasing willingness among consumers to pay for pet healthcare. The region’s demand profile is especially attractive to global vaccine makers because it supports both livestock and companion animal portfolios. For Instance, market studies indicate Asia Pacific is the fastest-growing regional market for veterinary vaccines, supported by expanding commercial livestock farming and pet ownership across both developed and emerging economies.

Major companies operating in Global Veterinary Vaccines Market are:

• Zoetis Inc.
• Merck & Co. Inc.
• Virbac SA
• Hester Biosciences Limited
• Elanco Animal Health
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Phibro Animal Health Corporation
• HIPRA

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The global veterinary vaccine market is experiencing significant expansion, driven by globalization and increased trade in animal products. Several related trends contribute to this growth: Emerging markets in Asia, Latin America, and Africa are witnessing a rise in demand for veterinary vaccines. As these regions undergo economic development and urbanization, the demand for animal protein and pet ownership is increasing, driving the need for vaccines. The international trade of animals and animal products necessitates compliance with international health and safety standards. This, in turn, boosts the demand for vaccines to ensure the health and safety of animals in transit. Vaccine manufacturers are forming collaborations and partnerships to expand their global presence and access new markets. This includes joint ventures, licensing agreements, and distribution partnerships”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Veterinary Vaccines Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Vaccine Type (Livestock Vaccine, Companion Animal Vaccine), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other), By Region & Competition 2021-2031F”, has evaluated the future growth potential of Global Veterinary Vaccines Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Veterinary Vaccines Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com